Latanoprost Macarthys Laboratories

Latanoprost, the active ingredient in Latanoprost Macarthys Laboratories, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure by increasing uveoscleral outflow, and is indicated for the treatment of open‑angle glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanoprost Macarthys Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide through regulated distribution channels. The company adheres to stringent quality standards and supports customers with technical and regulatory assistance.

Latanoprost is a prostaglandin analog used to reduce intra‑ocular pressure in glaucoma and ocular hypertension.

- Open-angle glaucoma: reduces intra‑ocular pressure, helping to prevent optic nerve damage. - Ocular hypertension: lowers elevated intra‑ocular pressure to reduce the risk of progression to glaucoma. - Secondary open-angle glaucoma: improves fluid outflow to control pressure in secondary forms of the disease.

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Darkening of iris: gradual brownish pigmentation.

Serious or Rare Side Effects: - Inflammatory eye reactions: uveitis or iritis. - Corneal edema: swelling of the cornea. - Vision loss: sudden decrease in visual acuity.

Latanoprost should be used with careful clinical oversight.

- Patient assessment: evaluate intra‑ocular pressure and ocular health before initiating therapy. - Contraindications: avoid use in patients with known hypersensitivity to latanoprost or any component of the formulation. - Monitoring: schedule regular eye examinations to detect changes in iris color or eyelash growth. - Drug interactions: inform prescriber of concurrent use of other prostaglandin analogues or ocular medications. - Pregnancy and lactation: safety not established; use only if potential benefit justifies potential risk. - Store at ambient temperature: keep the bottle in the original packaging, protect from light and freeze.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory eye drops: may reduce efficacy of latanoprost. - Systemic prostaglandin analogues: increased risk of systemic side effects.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive intra‑ocular pressure lowering effect. - Corticosteroid eye drops: may counteract pressure‑lowering effect. - Anticholinergic agents: potential for altered ocular surface.